Skip to main content

ATF6 Antibody (70B1413.1) - Azide and BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-80583

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-80583

Key Product Details

Validated by

Biological Validation

Species Reactivity

Validated:

Human, Mouse, Rat, Porcine, Plant, Rabbit

Applications

Chromatin Immunoprecipitation (ChIP), CyTOF-ready, Flow (Intracellular), Flow Cytometry, Immunoblotting, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry-Paraffin, Immunoprecipitation, Knockout Validated, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 kappa Clone # 70B1413.1

Format

Azide and BSA Free

Concentration

1 mg/ml

Product Summary for ATF6 Antibody (70B1413.1) - Azide and BSA Free

Immunogen

This monoclonal antibody was made against a partial protein containing amino acids 1-273 of human ATF6.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1 kappa

Description

(1) The ATF6 (IMG-273) has been cited to recognize both full-length and cleaved forms of ATF6. Please refer to the references in the Product Citation list for more comprehensive information.

(2) The ATF6 transfected cell lysate (40210) is recommended as a useful western blot positive control to run in parallel with your experimental samples.

(3) Active/cleaved forms of ATF6 are generated through proteolytic cleavage during ER stress. Different molecular weights have been described for cleaved forms. A sample protocol was first described in Luo and Lee (2002) wherein NIH3T3 cells were treated with the amino acid analogue azetidine (AzC), and full-length and cleaved forms ATF6 were detected with IMG-273. The results show that in addition to the major 90 kDa full length ATF6, protein bands over the range of 50-70 kDa were detectable following AzC treatment (Luo and Lee, 2002: Figure 4A, page 791). Many protocols and other cleaved forms have been described since, please consult the literature for additional information.

(4) For immunofluorescence microscopy, cells were fixed in methanol at -20 degrees C (Thomas et al, 2005). Thomas et al used immunofluorescence to identify ATF6 with IMG-273 in the nucleus.

(5) The active/cleaved 50 kDa nuclear form of ATF6 using IMG-273 has been found to be strongly expressed in certain tumor cell lines derived from B cell lymphoma (DEL), primary effusion lymphoma [BC-3 (ATCC CRL-2277), PEL-SY, HBL-6], lymphoblastic leukemia (DS-1) and multiple myeloma (RPMI-8226, NCI-H929), (Jenner et al. 2003).

(6) Cleaved 60 and 36 kDa ATF6 forms have also been described in the nucleus (Mao et al, 2007).

(7) The ATF6 antibody is reported to be specific for ATF6a, recognizing ATF6a but not ATF6b (Bommiasamy et al, 2009).

(8) In western blots, the binding pattern of ATF6 may vary. Researchers are encouraged to consult the body of literature citing the ATF6 IMG-273 antibody (see Product citation list) for additional information. General ATF6 literature is also helpful. For example, Yoshida (1998) show a multiple band pattern in HeLa in both untreated and stressed cells (Fig 11B). In this early landmark ATF6 publication, multiple bands were seen between the 66 and 116 kDa markers as well as one or more bands between the 45 and 66 kDa markers.

(9) We highly recommend the use of a maximum sensitivity ECL substrate (Femto sensitive) for efficient detection of this antibody in Western blot applications.

Scientific Data Images for ATF6 Antibody (70B1413.1) - Azide and BSA Free

Western Blot: ATF6 Antibody (70B1413.1)Azide and BSA Free [NBP2-80583]

Western Blot: ATF6 Antibody (70B1413.1)Azide and BSA Free [NBP2-80583]

Western Blot: ATF6 Antibody (70B1413.1) - Azide and BSA Free [NBP2-80583] - Lane 1: 293 cells transfected with full-length ATF6.
Lane 2: 293 cells transfected with partial length ATF6 (amino acids 1-373).
Lane 3: Untransfected 293 cells.

Western blots were probed with 4 ug/ml of the ATF6 monoclonal antibody and visualized with PicoTect Western Blot Chemiluminescence Substrate (10087K). Film was exposed for 1 min. The top arrow corresponds to the 90 kDa form of ATF6 described as full-length in the literature. The human full-length and partial length ATF6 plasmids are described in Luo and Lee (2002). Image from the standard format of this antibody.
Immunocytochemistry/ Immunofluorescence: ATF6 Antibody (70B1413.1) - Azide and BSA Free [NBP2-80583]

Immunocytochemistry/ Immunofluorescence: ATF6 Antibody (70B1413.1) - Azide and BSA Free [NBP2-80583]

Immunocytochemistry/Immunofluorescence: ATF6 Antibody (70B1413.1) - Azide and BSA Free [NBP2-80583] - Untreated HeLa cells were fixed in -20C methanol for 10 min, air dried and rehydrated in PBS at room temperature for 5 minutes. Cells were incubated with anti-ATF6 (1:20) for one hour at room temperature. ATF6 reactivity (green) was detected with anti-mouse Dylight-488 secondary antibody. Nuclei were counterstained with DAPI (blue). Note the ER localization of ATF6. Image from the standard format of this antibody.
Immunohistochemistry: ATF6 Antibody (70B1413.1) - Azide and BSA Free [NBP2-80583]

Immunohistochemistry: ATF6 Antibody (70B1413.1) - Azide and BSA Free [NBP2-80583]

Immunohistochemistry: ATF6 Antibody (70B1413.1) - Azide and BSA Free [NBP2-80583] - Human placenta, followed by biotinylated horse anti-mouse IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen. Dilution 10ug/ml Image from the standard format of this antibody.

Applications for ATF6 Antibody (70B1413.1) - Azide and BSA Free

Application
Recommended Usage

Chromatin Immunoprecipitation (ChIP)

1:10-1:500

Flow Cytometry

1 ug per million cells

Immunoblotting

reported in scientific literature (PMID 28550308)

Immunocytochemistry/ Immunofluorescence

1:10-1:500. Use reported in scientific literature (Thomas et al (2005); Kikuchi et al (2006))

Immunohistochemistry

1:10-1:500

Immunohistochemistry-Frozen

1:10-1:500. Use reported in scientific literature (Zhu et al (2008))

Immunohistochemistry-Paraffin

1:50. Use reported in scientific literature (van Kollenburg et al (2006))

Immunoprecipitation

1:10 - 1:500. Use reported in scientific literature (Hong et al (2004))

Western Blot

1-5 ug/ml
Application Notes
In Western blot do not use milk in the diluent as it can inhibit the observed signal. This antibody is CyTOF ready.
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein G purified

Formulation

TBS

Format

Azide and BSA Free

Preservative

No Preservative

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: ATF6

ATF6 is a constitutively expressed, endoplasmic reticulum (ER) membrane-anchored transcription factor. ATF6 is a key transcriptional activator of the unfolded protein response (UPR), which allows mammalian cells to maintain cellular homeostasis when they are subjected to environmental and physiological stresses that target the ER (reviewed in Shen, 2005 & Prywes, 2005). The C-terminus of ATF6 is located in the ER lumen and its N-terminal DNA binding domain faces the cytosol. AFT6 plays a key role in the ER stress response by transmitting the ER stress signal across the ER membrane into the nucleus. The induction of new gene expression by ATF6 is an important aspect of the ER stress response. In response to certain stress conditions, ATF6 translocates from the ER to the Golgi. The 90 kDa full-length ATF6 is processed within the Golgi to its active 50 kDa form through sequential cleavage by site-1 and site-2 proteases (S1P and S2P). Proteolytic activation of ATF6 in the ER stress response is a mechanism to regulate membrane-bound factors, and is referred to as regulated intramembrane proteolysis. The N-terminal active ATF6 translocates to the nucleus where it binds to ER stress-response elements in ER stress-response genes (ERSRGs). ATF6 is a potent transcriptional activator of ERSRGs. The fully glycosylated form of ATF6, a 670 amino acid protein, exhibits an electrophoretic mobility of ~90 kDa in denaturing SDS-gels, in part because of the glycosylated modifications. ATF6 has 3 consensus sites for N-linked glycosylation and exists constitutively as a glycosylated protein. Differentially glycosylated ATF6 forms may result from mutations or experimental treatment.

Long Name

Activating Transcription Factor 6

Alternate Names

ACHM7, ATF6 alpha

Gene Symbol

ATF6

Additional ATF6 Products

Product Documents for ATF6 Antibody (70B1413.1) - Azide and BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ATF6 Antibody (70B1413.1) - Azide and BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...